CID 121492554

Crystallomycin

Structural Information

Molecular Formula
C58H91N13O20
SMILES
CCC(C)CCCCC/C=C/CC(=O)N[C@@H](CC(=O)O)C(=O)N(C)[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H]([C@H](C)N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC2C(NC(=O)[C@H]3CCCCN3C2=O)C
InChI
InChI=1S/C58H91N13O20/c1-8-31(4)18-13-11-9-10-12-14-21-40(72)64-36(26-45(79)80)56(89)69(7)39(27-46(81)82)54(87)65-35(25-44(77)78)51(84)60-28-41(73)63-34(24-43(75)76)50(83)61-29-42(74)66-48(32(5)59)55(88)67-47(30(2)3)57(90)71-23-17-20-38(71)53(86)68-49-33(6)62-52(85)37-19-15-16-22-70(37)58(49)91/h12,14,30-39,47-49H,8-11,13,15-29,59H2,1-7H3,(H,60,84)(H,61,83)(H,62,85)(H,63,73)(H,64,72)(H,65,87)(H,66,74)(H,67,88)(H,68,86)(H,75,76)(H,77,78)(H,79,80)(H,81,82)/b14-12+/t31?,32-,33?,34-,35-,36-,37+,38-,39-,47-,48+,49?/m0/s1
InChIKey
AQZKCOXFXDOYRA-PVASSXKPSA-N
Compound name
(3S)-4-[[2-[[(2R,3S)-1-[[(2S)-1-[(2S)-2-[[(10aR)-3-methyl-1,5-dioxo-2,3,4,7,8,9,10,10a-octahydropyrido[1,2-a][1,4]diazepin-4-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-3-amino-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-[[2-[[(2S)-3-carboxy-2-[[(2S)-3-carboxy-2-[[(2S)-3-carboxy-2-[[(E)-10-methyldodec-3-enoyl]amino]propanoyl]-methylamino]propanoyl]amino]propanoyl]amino]acetyl]amino]-4-oxobutanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

71
References

59
Patents

1289.6504 Da
Monoisotopic Mass

-3.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 1290.6577 334.5
[M+Na]+ 1312.6396 314.4
[M-H]- 1288.6431 336.3
[M+NH4]+ 1307.6842 327.8
[M+K]+ 1328.6136 308.9
[M+H-H2O]+ 1272.6477 303.7
[M+HCOO]- 1334.6486 326.4
[M+CH3COO]- 1348.6643 327.2
[M+Na-2H]- 1310.6251 366.4
[M]+ 1289.6499 340.5
[M]- 1289.6509 340.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe